Company news
|
31 August 2011 HIV infection diagnostics: new Alkor Bios test systems got registration certificate from Federal Service on Surveillance in Healthcare and Social Development of Russian FederationThe two latest innovative elaborations of biotechnological group Alkor Bio – reagents kits for HIV infection diagnostics got registration certificate from Federal Service on Surveillance in Healthcare and Social Development of Russian Federation. The «HivEIA-anti-HIV-1,2» diagnostic kit is intended for qualitative immunoenzymometric analysis of antibodies for human immunodeficiency virus in serum & blood plasma. The «HivEIA-HIV-Ag/Ab» diagnostic kit is intended for qualitative immunoenzymometric analysis of antigen P24 & antibodies for human immunodeficiency virus in serum & blood plasma.
|
30 June 2011 The innovation project of company GENE was presented at the Russian- American symposium in Moscow On the 27-th - 28-th of June company GENE, a member of biotechnological group Alkor Bio, presented the project «The development of diagnostic kit MB25-CHIP using nanobiotechnology of DNA-microchips for diagnostics of cystic fibrosis & abnormality of reproductive function» at the first international Russian-American Symposium «Innovation technologies in genetics & child epileptology».
|
23 June 2011 Group of Companies "Alkor Bio" is one of the participants on the exhibition "The Best Russian Projects - 2011"On the 22-nd of June the grand ceremony of opening the exhibition “The Best Russian Projects - 2011” take place in the international press-center FGU «Government complex «The Palace of congresses». The exhibition is run with support of the State Duma, Federation Soviet, the Public Chamber. Over the years of the exhibition existence more than 500 companies and organization take place in it. 50 projects from 20 regions was presented for this once.
|
|
03 June 2011 Trans-Technologies, Ltd acquires Bioactive Wound Dressing patent In May 2011, Russian biotechnological company Trans-Technologies, Ltd acquired patent for bioactive wound dressing. This is a new, improved variant of the “artificial human skin” – collagen-based biomaterial for skin wound healing.
|
01 June 2011 Company "GENE" expands the list of CE-mark productsIn May 2011 the kit «PharmacoGANE-ACG» for detecting individual sensitivity of oral anticoagulants and «pharmacoGENE –SLC6A4» for detecting individual sensitivity of antidepressants successfully passed the procedure of DirectiveCE valuation conformity and got CE-mark.
|
03 May 2011 Diagnostic kit "ThromboGENE" producing by company "GENE" received the registration certificate of Russian Federal Service for the Supervision of Public Health and Social DevelopmentThis diagnostic system, which is used for detection genetic thrombosis predisposition and inherited trombophilia, got the registration certificate. |